Literature DB >> 23001374

Negatively charged superparamagnetic iron oxide nanoparticles: a new blood-pooling magnetic resonance contrast agent.

Norihisa Nitta1, Keiko Tsuchiya, Akinaga Sonoda, Shinichi Ota, Noritoshi Ushio, Masashi Takahashi, Kiyoshi Murata, Satoshi Nohara.   

Abstract

PURPOSE: Our purpose was to investigate the utility of superparamagnetic iron-oxide nanoparticles (SPIO) as a blood-pooling contrast agent at magnetic resonance imaging (MRI).
MATERIALS AND METHODS: We studied four contrast agents: carboxymethyl-diethylaminoethyl dextran magnetite SPIO (CMEADM-S, diameter 54 nm), negatively charged CMEADM ultrasmall SPIO (CMEADM-U, 32 nm), alkali-treated dextran magnetite SPIO (ATDM-S, 55 nm), and ATDM ultrasmall SPIO (ATDM-U, 28 nm) carrying a neutral charge. Each contrast agent (80 μmol/kg) was injected intraperitoneally into apolipoprotein E (apoE) mice and the tissue iron concentration was measured 30-, 60-, 180-, and 300-min later by nuclear MR. For MR angiographic (MRA) evaluation, we injected the agents into the auricular vein of four groups of 15 rabbits. Immediately and 30-, 60-, 180-, and 300-min later, three rabbits from each group were subjected to MRI. The organ/background signal ratio (SR) was calculated. Statistical analyses were performed with Tukey's honestly significant difference (HSD) test.
RESULTS: At 60 and 180 min, blood-iron concentration of CMEADM-U was significantly different from other contrast agents. In the abdominal aorta and inferior vena cava, SR of CMEADM-U was higher at 180 and 300 min than of the other contrast agents. In the thoracic aorta, there was no difference in SR at 300 min between CMEADM-U and CMEADM-S.
CONCLUSION: Negatively charged SPIO nanoparticles may be useful as a blood-pooling contrast agent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001374     DOI: 10.1007/s11604-012-0133-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  20 in total

Review 1.  Cellular magnetic resonance imaging: current status and future prospects.

Authors:  Ali S Arbab; Wei Liu; Joseph A Frank
Journal:  Expert Rev Med Devices       Date:  2006-07       Impact factor: 3.166

2.  Hepatocellular carcinoma with marginal superparamagnetic iron oxide uptake on T2*-weighted magnetic resonance imaging: histopathologic correlation.

Authors:  Kousei Ishigami; Tsuyoshi Tajima; Nobuhiro Fujita; Akihiro Nishie; Yoshiki Asayama; Daisuke Kakihara; Tomohiro Nakayama; Daisuke Okamoto; Akinobu Taketomi; Ken Shirabe; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2011-02-02       Impact factor: 3.528

3.  Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10.

Authors:  Anuradha Saokar; Michael S Gee; Tina Islam; Peter R Mueller; Mukesh G Harisinghani
Journal:  Clin Imaging       Date:  2010 Nov-Dec       Impact factor: 1.605

4.  Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.

Authors:  Thomas Allkemper; Christoph Bremer; Lars Matuszewski; Wolfgang Ebert; Peter Reimer
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

5.  Assessment of age modulated vascular inflammation in ApoE-/- mice by USPIO-enhanced magnetic resonance imaging.

Authors:  Monica Sigovan; Amine Bessaad; Hasan Alsaid; Eric Lancelot; Claire Corot; Bruno Neyran; Nicolas Provost; Zouher Majd; Magali Breisse; Emmanuelle Canet-Soulas
Journal:  Invest Radiol       Date:  2010-11       Impact factor: 6.016

Review 6.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Authors:  Y X Wang; S M Hussain; G P Krestin
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

7.  Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.

Authors:  Hye Jin Yoo; Jeong Min Lee; Jae Young Lee; Se Hyung Kim; Soo Jin Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Invest Radiol       Date:  2009-12       Impact factor: 6.016

8.  Detection of hepatocellular carcinoma with ferucarbotran (resovist)-enhanced breath-hold MR imaging: feasibility of 10 minute-delayed images.

Authors:  Kazuhiro Saito; Hiroaki Shindo; Taizo Ozuki; Aimi Ishikawa; Fumio Kotake; Yoko Shimazaki; Kimihiko Abe
Journal:  Magn Reson Med Sci       Date:  2008       Impact factor: 2.471

9.  Dynamic contrast-enhanced perfusion MR imaging with SPIO: a pilot study.

Authors:  Shiori Amemiya; Masaaki Akahane; Shigeki Aoki; Osamu Abe; Kyosuke Kamada; Nobuyuki Saito; Kuni Ohtomo
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

10.  Histological study of the biodynamics of iron oxide nanoparticles with different diameters.

Authors:  Keiko Tsuchiya; Norihisa Nitta; Akinaga Sonoda; Ayumi Nitta-Seko; Shinichi Ohta; Hideji Otani; Masashi Takahashi; Kiyoshi Murata; Katsutoshi Murase; Satoshi Nohara; Kenichi Mukaisho
Journal:  Int J Nanomedicine       Date:  2011-08-02
View more
  1 in total

1.  Feasibility of Macrophage Plaque Imaging Using Novel Ultrasmall Superparamagnetic Iron Oxide in Dual Energy CT.

Authors:  Hideyuki Sato; Shinichiro Fujimoto; Yosuke Kogure; Hiroyuki Daida
Journal:  Eur J Radiol Open       Date:  2018-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.